Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old

NCT00578734 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Hypoxemic Respiratory Failure

Interventions

DRUG: Lucinactant
OTHER: Sham Comparator

Sponsor

Windtree Therapeutics